Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellebrite

15.98
-0.1350-0.84%
Volume:937.24K
Turnover:15.03M
Market Cap:3.90B
PE:-24.34
High:16.22
Open:16.19
Low:15.91
Close:16.11
52wk High:26.30
52wk Low:13.10
Shares:244.00M
Float Shares:112.43M
Volume Ratio:0.56
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6564
EPS(LYR):-1.3510
ROE:-81.98%
ROA:5.95%
PB:9.54
PE(LYR):-11.82

Loading ...

Craig-Hallum Keeps Their Buy Rating on Cellebrite DI (CLBT)

TIPRANKS
·
Aug 20

Stock Track | Cellebrite Soars 5.20% Following Strong Quarterly Results and Upbeat Earnings Forecast

Stock Track
·
Aug 19

Cellebrite participates in a conference call with Craig-Hallum

TIPRANKS
·
Aug 19

Earnings Beat: Cellebrite DI Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.
·
Aug 19

Cellebrite DI Second Quarter 2025 Earnings: EPS Beats Expectations

Simply Wall St.
·
Aug 16

Cellebrite participates in a conference call with JPMorgan

TIPRANKS
·
Aug 15

Cellebrite DI (CLBT) Gets a Buy from Deutsche Bank

TIPRANKS
·
Aug 15

Cellebrite DI Announces Shareholder Meeting Amidst Strategic Growth and Leadership Changes

TIPRANKS
·
Aug 15

Cellebrite (CLBT) Is Up 10.6% After Return to Profitability and CEO Appointment Has the Bull Case Changed?

Simply Wall St.
·
Aug 15

Cellebrite DI Reports Strong Financial Growth in H1 2025

TIPRANKS
·
Aug 15

Cellebrite price target lowered to $24 from $25 at BofA

TIPRANKS
·
Aug 15

Cellebrite's New Chief Beat Cancer a Month Before Joining C-Suite -- Market Talk

Dow Jones
·
Aug 15

Cellebrite Shares Pop, Shaking Off Outlook Cut

Dow Jones
·
Aug 15

Cellebrite DI Is Maintained at Buy by Needham

Dow Jones
·
Aug 15

Positive Outlook for Cellebrite DI: Strategic Developments and Financial Discipline Justify Buy Rating

TIPRANKS
·
Aug 15

Stock Track | Cellebrite Soars 5.08% on Strong Q2 Results, New CEO Appointment, and Positive Outlook

Stock Track
·
Aug 14

Stock Track | Cellebrite Soars 5% Pre-Market on Strong Q2 Results, New CEO Appointment, and Positive Outlook

Stock Track
·
Aug 14

Stock Track | Cellebrite Plummets 5% as Q2 Earnings Miss Estimates and Full-Year Guidance Lowered

Stock Track
·
Aug 14

Stock Track | Cellebrite Plummets 5% Pre-Market Despite Q2 Beat as Full-Year Guidance Lowered

Stock Track
·
Aug 14

Sector Update: Tech Stocks Decline Premarket Thursday

MT Newswires Live
·
Aug 14